Tramadol - interaction with SSRIs and with Morphine - September 2008 Prof E Shipton Christchurch School of Medicine Clinical Director: Pain ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Tramadol – interaction with SSRIs and with Morphine September 2008 Prof E Shipton Christchurch School of Medicine Clinical Director: Pain Management Centre
Serotonin Syndrome (SS) • all drugs that directly/indirectly central serotonin neurotransmission at postsynaptic 5-HT(2A) receptors in nervous system, on platelet surfaces, on vascular endothelium, can SS • spectrum serotonergic adverse effects to intra- synaptic serotonin concentration-related toxidrome • When serotonergic drugs with different mechanisms of action are mixed together intra-synaptic serotonin • low incidence • dose-related; rapid onset and progression (hours) • no formal test for the diagnosis of SS
Diagnosis of SS • diagnostic criteria are confusing • vague, non-specific clinical features • combination of altered mental status, neuromuscular hyperactivity, and autonomic hyperactivity • exclude common mental status adverse effects from centrally acting pharmaceuticals • Differential - neuroleptic malignant syndrome; anticholinergic delirium; malignant hyperthermia
Neuromuscular hyperactivity Clonus, Autonomic hyperactivity myoclonus, diaphoresis, fever hyper-reflexia, tachycardia shivering, tachypnoea hypertonia, flushing, rigidity hyperthermia Altered mental status Whytes Agitation, anxiety Distinguishing hypomania Features confusion
Hunter Serotonin Toxicity Criteria Serotonergic S agent ingestion or E overdose R O T Spontaneous Yes O N clonus I No Agitation or N diaphoresis or Inducible or Plus hypertonia Yes T and pyrexia O ocular clonus X (> 38 C) I Plus Yes C Tremor Hyperreflexia I No No T Y Not clinically significant serotonin toxicity
Drugs associated with SerotoninToxicity • SSRIs - fluoxetine, fluvoxamine, paroxetine, citalopram, sertraline, escitalopram • SNRIs - venlafaxine, duloxitine, milnacipran, sibutramine • TCAs - clomipramine, imipramine • Opioids - pethidine, fentanyl, methadone, dextromethorphan, dextropropoxyphene, tramadol • Anti-histamines - chlorpheniramine, brompheniramine • Serotonin releasers - fenfluramine, amphetamine, MDMA (ectasy) • Monoamine oxidase inhibitors – moclobemide (reversible), linzolid; tranylcypromine, phenelzine • Others - lithium, tryptophan
Pathways by which serotonin acts within the central nervous system (MJA 2007;187:361-5)
Cyproheptadine (5-HT2A antag) 12 mg orally Chlorpromazine (5-HT2A antag) or crushed via 12.5–25 mg i.v nasogastric after fluid tube, then load, then 25 4–8 mg mg orally or every 6 h iv every 6 h Benzodiazepines Supportive to reduce passive + active cooling pyrexia, sedation, intubation, agitation, muscle paralysis + ventilation seizures
Tramadol
Tramadol and SSRIs • Tramadol - atypical opioid analgesic with partial µ agonism; central re-uptake inhibition of 5HT and noradrenaline; serotonin release (induced at high doses) • Tramadol partial inhibition of serotonin uptake (especially in drug combinations) cerebral serotonin activity • SSRIs can inhibit the CYP2D6 iso-enzyme metabolising tramadol therapeutic overdose of tramadol idiosyncratic induction of SS (in susceptible individuals)
Tramadol and SSRIs • SS - rare with tramadol (less than 20 cases in PUBMED); used over 30 years with > 5 billion treatment days • Most frequent (and almost the only) fatal combination is: - MAOIs with SSRIs • Safety Practice Points - use no more than two SRI drugs; use low doses of combinations - e.g. fluoxetine 20 mg plus tramadol SR 100 mg bd - if fluoxetine dose to 40 mg, reduce and stop tramadol
Tramadol and Morphine • Multimodal (or balanced analgesia) is a validated concept in the postoperative period - combination of analgesic drugs with different pharmacological properties - supra-additive effects of paracetamol/tramadol on analgesia (anti-hyperalgesia) • Synergy between opioids reported in animal studies • Remifentanil (0.2 ug kg-1) to tramadol (0.2 mg kg-1), with 10-min lockout times, for PCA postop analgesia + patient comfort after abdominal surgery, without sedation or respiratory depression (Unlugenc H. Eur J Anaesthesiol 2008; June 05:1)
Tramadol and Paracetamol (Filitz J et al, Pain 2008;136:262-70) Double-blind and placebo-controlled study with a cross-over in 17 volunteers using high current intensity TENS (a) Pain ratings and (b) Areas of pinprick-hyperalgesia were significantly reduced after combination of paracetamol and tramadol (means ± SE).
Tramadol 2500-4000 x less mu opioid receptor CYP2D6 (sparteine affinity vs morphine oxidase) O-desmethyl tramadol inhibits 9-450 x less mu neuronal opioid receptor reuptake of affinity vs morphine serotonin and activates descending noradrenaline mono-aminergic inhibitory paths
Tramadol Morphine Tramadol Morphine Enantiomer - weak mu opioid mu opioid agonist - Activates effect descending analgesic paths Enantiomer – inhibits Inhibits sub P release at spinal noradrenaline/serotonin uptake cord synapse + activates descending mono- Hyperpolarises post-synaptic aminergic inhibitory paths inter-neurones Potency (weight for weight) intravenous 1 10 epidural 1 13
Tramadol Morphine • Does combination increase efficacy with less adverse effects? Yes! No! • Evidence from studies on post-operative pain for tramadol/morphine combination is mixed
RCT - addition of tramadol to morphine via PCA after total knee arthroplasty (Stiller CO et al, Acta Anaesthesiol Scand 2007;51:322-30) Spinal anaesthesia 63 patients randomised VAS = 40/100 Tramadol 100 VAS = 40/100 mg over 20 min PCA Saline iv every iv every 6 h for 24h morphine B1 6 h for 24 h (total 400 mg/24 h) mg; LO 6 min (Max 35mg/6h) VAS of pain, nausea, sedation - every hour for 6 h; prior to infusion of study drugs and 1 h after infusion; final assessment at 24 h
Median (and interquartile range) of Average VAS after administration of tramadol 100mg 6 hourly for ‘intention to treat’ population (Mo – morphine) (Stiller CO et al, Acta Anaesthesiol Scand 2007;51:322-30) no significant difference in pain intensity (sedation, nausea)
Median Effective Dose of Tramadol and Morphine for Postoperative Patients: a double-blind, randomised, two-stage prospective study in 90 postoperative patients after slightly or moderately painful surgery (Marcou TA et al. Anesth Analg 2005;100:469-74) Identical anaesthetic; Three Groups (n = 30) using an up down allocation technique; NPS (0–10) at T0 min; at T 20 min if NPS > 3, dose for next patient; at T 20 min if NPS < 3 dose for next patient Tramadol group Morphine group Combined Group initial doses 100 initial doses 5 40 (6.67) mg: 3 (0.5) mg mg (increments mg (increments tramadol:morphine 10 mg) 1 mg dosing ratio; isobolographic analysis
Pain Intensity in Three groups by NPS on arrival in Recovery (T0) (Box plot with median, 25th–75th, and 10th–90th percentiles) (Marcou TA et al. Anesth Analg 2005;100:469-74) NPS was similar in the three groups with median of 5
Sequence of dosing in groups morphine, tramadol, and tramadol + morphine with up-and-down allocation technique ED50 is represented by dashed lines no significant in adverse effects except for dry mouth in combination stars are failures (ineffective analgesia) and open circles are success (effective analgesia)
Median Effective Dose of Tramadol and Morphine for Postoperative Patients: a double-blind, randomised, two-stage prospective study in 90 postoperative patients after slightly or moderately painful surgery (Marcou TA et al. Anesth Analg 2005;100:469-74) ED50 values (95% CI) of ED50 values (95% CI) of Tramadol = 86 mg Morphine = 5.7 mg (57–115 mg) (4.2–7.2 mg) ED50 of combination was Tramadol 72 mg (62–82 mg) and Morphine 5.4 mg (4– 6.2 mg) = infra-additive ?
A Double-blind, RCT - addition of a Tramadol Infusion to Morphine PCA in 69 patients after Abdominal Surgery: (Webb AR et al. Anesth Analg 2002;95:1713-8) end surgery initial end surgery initial loading dose of loading dose of Tramadol (1 mg/kg) Saline postoperative infusion postoperative infusion of Tramadol at 0.2 mg of Saline kg-1 · h-1 morphine B 1 mg; LO 5 min via PCA
Mean (95% CI) Values for analgesic Efficacy four hourly (1 = excellent, 2 = good, 3 = satisfactory, 4 = poor, and 5 = very poor) and PCA Morphine Consumption 48 h after Surgery (Webb AR et al. Anesth Analg 2002;95:1713-8) no evidence of increased adverse effects in patients receiving tramadol
RCT- Effects of a single dose of tramadol prior to extubation on post-operative pain and morphine consumption after coronary artery bypass surgery (But AK et al, Acta Anaesthesiol Scand 2007;51:601-6) Similar anaesthesia (fentanyl 5 ug/kg; maintenance 30 ug/kg); propofol 1mg/kg/h to pre-extubation) 60 Patients randomised into two groups Group T - Tramadol 1 Group P - 2 ml of mg/kg 1 h before Saline 0.9% 1 h extubation before extubation PCA (for 24h) morphine B1 mg; LO 7 min Max 20mg/4h
Mean Post-operative Pain Scores (± SD), group P (Saline) vs.T (Tramadol) († p < 0.01 * p < 0.05) (plus morphine PCA) (But AK et al, Acta Anaesthesiol Scand 2007;51:601) pain scores significantly higher 1-4 h in group P [total morphine consumption reduced in group T over 24h (p < 0.01)]
Evidence for tramadol/morphine combination from studies on post-operative pain is mixed Need more prospective double-blind randomised controlled studies in a cross-over design or where variables are minimised
You can also read